Dennis Mcloughlin serves as Executive at Pacira BioSciences, Inc., where they oversee executive responsibilities. Since joining the company, Dennis Mcloughlin has executed 11 insider transactions totaling $608.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 7, 2023 involved selling 1,057 shares valued at $40.0K.
Dennis Mcloughlin currently holds 38,115 shares of Pacira BioSciences, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dennis Mcloughlin has been a net seller of PCRX stock. They have purchased $0 and sold $608.9K worth of shares.
Dennis Mcloughlin's most recent insider trade was on Jun 7, 2023, when they sold 1,057 shares at $37.87 per share.
Get notified when new Form 4 filings are submitted
| $38.99 |
| Discretionary |
| Jun 8, 2022 | PCRX | $0 | Award | 7,950 | $N/A | Discretionary |
| Jun 6, 2022 | PCRX | $131.3K | Sale | 2,140 | $61.37 | Discretionary |
| Jun 9, 2021 | PCRX | $0 | Award | 6,000 | $N/A | Discretionary |
| Jun 4, 2021 | PCRX | $115.7K | Sale | 1,895 | $61.04 | Discretionary |
| Jun 9, 2020 | PCRX | $0 | Award | 14,000 | $N/A | Discretionary |
| Jun 4, 2020 | PCRX | $67.0K | Sale | 1,447 | $46.33 | Discretionary |
| Dec 16, 2019 | PCRX | $168.1K | Sale | 3,671 | $45.79 | Discretionary |
| Jun 5, 2019 | PCRX | $0 | Award | 5,600 | $N/A | Discretionary |
| Jun 4, 2019 | PCRX | $47.2K | Sale | 1,099 | $42.91 | Discretionary |